Anti-KIDINS220 monoclonal antibody

Pre-made anti-KIDINS220 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to KIDINS220/KIDINS220 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1053-Ab-1/ GM-Tg-hg-IP1053-Ab-2Anti-Human KIDINS220 monoclonal antibodyHuman
GM-Tg-rg-IP1053-Ab-1/ GM-Tg-rg-IP1053-Ab-2Anti-Rat KIDINS220 monoclonal antibodyRat
GM-Tg-mg-IP1053-Ab-1/ GM-Tg-mg-IP1053-Ab-2Anti-Mouse KIDINS220 monoclonal antibodyMouse
GM-Tg-cynog-IP1053-Ab-1/ GM-Tg-cynog-IP1053-Ab-2Anti-Cynomolgus/ Rhesus macaque KIDINS220 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1053-Ab-1/ GM-Tg-felg-IP1053-Ab-2Anti-Feline KIDINS220 monoclonal antibodyFeline
GM-Tg-cang-IP1053-Ab-1/ GM-Tg-cang-IP1053-Ab-2Anti-Canine KIDINS220 monoclonal antibodyCanine
GM-Tg-bovg-IP1053-Ab-1/ GM-Tg-bovg-IP1053-Ab-2Anti-Bovine KIDINS220 monoclonal antibodyBovine
GM-Tg-equg-IP1053-Ab-1/ GM-Tg-equg-IP1053-Ab-2Anti-Equine KIDINS220 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1053-Ab-1/ GM-Tg-hg-IP1053-Ab-2; GM-Tg-rg-IP1053-Ab-1/ GM-Tg-rg-IP1053-Ab-2;
GM-Tg-mg-IP1053-Ab-1/ GM-Tg-mg-IP1053-Ab-2; GM-Tg-cynog-IP1053-Ab-1/ GM-Tg-cynog-IP1053-Ab-2;
GM-Tg-felg-IP1053-Ab-1/ GM-Tg-felg-IP1053-Ab-2; GM-Tg-cang-IP1053-Ab-1/ GM-Tg-cang-IP1053-Ab-2;
GM-Tg-bovg-IP1053-Ab-1/ GM-Tg-bovg-IP1053-Ab-2; GM-Tg-equg-IP1053-Ab-1/ GM-Tg-equg-IP1053-Ab-2
Products NameAnti-KIDINS220 monoclonal antibody
Formatmab
Target NameKIDINS220
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-KIDINS220 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1053-Ag-1Recombinant multi-species KDIS/ KIDINS220/ ARMS protein


    Target information

    Target IDGM-IP1053
    Target NameKIDINS220
    Gene ID57498,77480,116478,693522,475657,101096227,536267,100057204
    Gene Symbol and Synonyms3110039L19Rik,ARMS,C330002I19Rik,KIDINS220,mKIAA1250,SINO,VENARG
    Uniprot AccessionQ9ULH0,Q9EQG6
    Uniprot Entry NameKDIS_HUMAN,KDIS_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000134313
    Target ClassificationN/A

    The target: KIDINS220, gene name: KIDINS220, also named as ARMS, SINO. This gene encodes a transmembrane protein that is preferentially expressed in the nervous system where it controls neuronal cell survival, differentiation into exons and dendrites, and synaptic plasticity. The encoded protein interacts with membrane receptors, cytosolic signaling components, and cytoskeletal proteins, serving as a scaffold that mediates crosstalk between the neurotrophin pathway and several other intracellular signaling pathways. Aberrant expression of this gene is associated with the onset of various neuropsychiatric disorders and neurodegenerative diseases, including Alzheimer's disease. Naturally occurring mutations in this gene are associated with a syndrome characterized by spastic paraplegia, intellectual disability, nystagmus and obesity. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2017].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.